Salmon Latest Biotechnology to Help Brain and Spinal Regeneration
Traumatic brain injury and spinal cord injury may have another treatment to minimize injury in the future. A biotech company in Maine called Sea Run Holdings Inc. seeks to enter the blood and spinal regeneration markets using salmon-plasma proteins. The effort has been in the works for the last 12 years. One of the efforts by the company is the development of a product that shows promise in the treatment of spinal cord and traumatic brain injury. Product testing has been applied successfully on brain and spine injured animals in suppressing inflammation and pain while even regenerating neurons. The company is looking to move to human clinical trials in the next year. Salmon is rich in Omega 3 fatty acid s that are the basic building blocks for nerve tissue and brain cells. Over the past five years funding has been provided through more than $4 million in grants from the National Institutes of Health and the U.S. Department of Defense.
